{"id":4344,"company":{"country":"IL","currency":"USD","exchange":"NYSE MKT LLC","ipo":"2018-12-18","marketCap":22.368017196655273,"name":"Biomx Inc","phone":"972723942377","outstanding":69.80999755859375,"symbol":"PHGE","website":"https://www.biomx.com/","industry":"Biotechnology"},"price":1.28745,"year":2024,"month":8,"day":28,"weekday":"Wednesday","title":"Impact of government policies on Biomx Inc stock market behavior","date":"2024-08-28","url":"/posts/2024/08/28/PHGE","content":[{"section":"Positive impact on Biomx Inc stock market behavior","text":"1. Tax cuts: If the government introduces tax cuts, Biomx Inc may benefit from increased profitability due to lower tax expenses. This could lead to an increase in stock prices as investors perceive the company as more attractive."},{"section":"Negative impact on Biomx Inc stock market behavior","text":"1. Tax hikes: Should the government impose higher taxes, Biomx Inc may suffer from reduced profitability due to higher tax obligations. This could result in a decrease in stock prices as investors view the company as less financially viable."},{"section":"Indirect impact on Biomx Inc stock market behavior","text":"1. Government subsidies: If the government provides subsidies or incentives related to Biomx Inc's industry, such as tax credits for research and development activities, it could positively impact the company's stock market behavior. This is because subsidies can enhance profitability and investor confidence in the company's future prospects, potentially leading to increased stock prices."},{"section":"Market sentiment impact","text":"1. Confidence in government policies: Overall market sentiment towards government policies, including tax changes, can impact Biomx Inc's stock market behavior. Positive sentiment towards pro-business policies may result in increased investor confidence and stock prices, while negative sentiment may lead to a decline in stock prices."},{"section":"Investor behavior","text":"1. Tax planning: Changes in tax policies can influence investor behavior, including their investment decisions related to Biomx Inc. For example, if new tax regulations incentivize certain investment strategies, investors may adjust their portfolio allocations, which could impact stock prices."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1723820100,"headline":"UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split","id":129409789,"image":"https://s.yimg.com/ny/api/res/1.2/fuD1mglZv6.FwLXJ.FDx9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0zMjU-/https://media.zenfs.com/en/globenewswire.com/8e338321e5657eef2075cbc0a640c404","symbol":"PHGE","publisher":"Yahoo","summary":"In a release issued under the same headline yesterday by BiomX (NYSE American: PHGE), the third and fourth paragraphs have been updated to include information regarding adjustment of outstanding units following the reverse stock split GAITHERSBURG, Md., Aug. 16, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday by BiomX (NYSE American: PHGE), the third and fourth paragraphs have been updated to include information regarding adjustment of outstanding units following t","url":"https://finance.yahoo.com/news/units-biomx-inc-announces-1-145500475.html"},{"category":"company","date":1723796160,"headline":"Buy Rating for BiomX: Solid Financials and Promising Clinical Pipeline Signal Strong Future Performance","id":129404955,"image":"","symbol":"PHGE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3603064840"},{"category":"company","date":1723787280,"headline":"BiomX Buy Rating Affirmed by Analyst Michael Higgins on Strong Clinical Progress and Strategic Acquisitions","id":129404956,"image":"","symbol":"PHGE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3602948567"},{"category":"company","date":1723723389,"headline":"BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript","id":129376285,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"PHGE","publisher":"SeekingAlpha","summary":"BiomX Inc. (NYSE:NYSE:PHGE) Q2 2024 Earnings Call Transcript August 15, 2024 8:00 AM ETCompany ParticipantsMarina Wolfson - CFOJonathan Solomon -...","url":"https://seekingalpha.com/article/4714888-biomx-inc-phge-q2-2024-earnings-call-transcript"},{"category":"company","date":1723717800,"headline":"BiomX Inc. Announces 1-for-10 Reverse Stock Split","id":129379592,"image":"https://s.yimg.com/ny/api/res/1.2/fuD1mglZv6.FwLXJ.FDx9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0zMjU-/https://media.zenfs.com/en/globenewswire.com/8e338321e5657eef2075cbc0a640c404","symbol":"PHGE","publisher":"Yahoo","summary":"GAITHERSBURG, Md., Aug. 15, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it intends to effect a one-for-ten reverse split (the \"Reverse Stock Split\") of the Company’s common stock (the \"Common Stock\"). The Common Stock will continue to trade on the NYSE American under the existing symbol “PHGE” and will begin tradi","url":"https://finance.yahoo.com/news/biomx-inc-announces-1-10-103000947.html"},{"category":"company","date":1723717800,"headline":"BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates","id":129379591,"image":"https://s.yimg.com/ny/api/res/1.2/fuD1mglZv6.FwLXJ.FDx9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0zMjU-/https://media.zenfs.com/en/globenewswire.com/8e338321e5657eef2075cbc0a640c404","symbol":"PHGE","publisher":"Yahoo","summary":"BiomX anticipates reporting important results in 2025 for two clinical assets from the Company’s leading phage therapy pipeline Recent stockholder vote approves conversion of Series X Non-Voting Convertible Preferred Stock (issued upon merger with Adaptive Phage Therapeutics and concurrent financing) to BiomX’s common stock Company will host a conference call and webcast today at 8:00 am ET GAITHERSBURG, Md., Aug. 15, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Com","url":"https://finance.yahoo.com/news/biomx-reports-second-quarter-2024-103000555.html"},{"category":"company","date":1723711560,"headline":"BiomX GAAP EPS of -$0.07","id":129376949,"image":"","symbol":"PHGE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601717220"},{"category":"company","date":1723701840,"headline":"BiomX to implement a reverse stock split","id":129376952,"image":"","symbol":"PHGE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601585635"},{"category":"company","date":1723700160,"headline":"BiomX announces 1-for-10 reverse stock split","id":129376953,"image":"","symbol":"PHGE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601562412"},{"category":"company","date":1723625760,"headline":"PHGE Stock Earnings: BiomX Reported Results for Q2 2024","id":129376954,"image":"","symbol":"PHGE","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3601130272"}]}